INVESTOR ALERT: Approximately 48 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc.
(firmenpresse) - NEW ORLEANS, LA -- (Marketwire) -- 04/04/12 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until to file lead plaintiff applications in a securities class action lawsuit against BioSante Pharmaceuticals, Inc. ("BioSante" or the "Company") (NASDAQ: BPAX), if they purchased the Company's securities during the period between February 12, 2010 and December 15, 2011 (the "Class Period"). The lawsuit was filed in the United States District Court for the Northern District of Illinois, Eastern Division.
If you purchased securities of BioSante and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis Kahn (), toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or KSF Director of Client Relations Neil Rothstein, Esq. (), toll free at 877-694-9510, or via cell phone any time at 330-860-4092. If you wish to serve as a lead plaintiff, you must apply to the Court by April 6, 2012.
BioSante and its Chief Executive Officer are charged with issuing materially false and misleading statements, during the Class Period, in violation of Section 10(b) and 20(a) of the Exchange Act and Rule 10b-5.
On December 14, 2011, shares of BioSante declined by over 75%, after investors learned, for the first time, that LibiGel failed in efficacy tests. This drug failure was in stark contrast to the positive statements made during the Class Period.
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action and shareholder derivative litigation with offices in New York and Louisiana. KSF's lawyers have significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders.
To learn more about KSF, you may visit .
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn
Managing Partner
877-515-1850
or after hours via cell phone 504-301-7900
206 Covington St.
Madisonville, LA 70447
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.04.2012 - 17:00 Uhr
Sprache: Deutsch
News-ID 132234
Anzahl Zeichen: 0
contact information:
Town:
NEW ORLEANS, LA
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 231 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INVESTOR ALERT: Approximately 48 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
Kahn Swick & Foti, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
